BCc1 treatment significantly increased Beclin-1 expression, comparable to cyclophosphamide-induced modulation, suggesting a nuanced mechanism that balances autophagy activation for tumor suppression without triggering cytoprotective resistance. This evidence concerns the gene BECN1 and neoplasm.